Free Trial

Theracryf (TCF) Competitors

GBX 0.22 +0.01 (+4.76%)
As of 11:57 AM Eastern

TCF vs. HARL, SOS, VEL, ING, NWT, SPO, IX, TREE, STL, and HWC

Should you be buying Theracryf stock or one of its competitors? The main competitors of Theracryf include Harland & Wolff Group (HARL), Sosandar (SOS), Velocity Composites (VEL), Ingenta (ING), Newmark Security (NWT), Sportech (SPO), i(x) Net Zero (IX), Cambium Global Timberland (TREE), Stilo International (STL), and Highway Capital (HWC). These companies are all part of the "banking" industry.

Theracryf vs. Its Competitors

Theracryf (LON:TCF) and Harland & Wolff Group (LON:HARL) are both small-cap banking companies, but which is the superior stock? We will contrast the two businesses based on the strength of their media sentiment, profitability, institutional ownership, earnings, risk, valuation, analyst recommendations and dividends.

Harland & Wolff Group has a net margin of -49.57% compared to Theracryf's net margin of -792.17%. Harland & Wolff Group's return on equity of 0.00% beat Theracryf's return on equity.

Company Net Margins Return on Equity Return on Assets
Theracryf-792.17% -99.97% -48.26%
Harland & Wolff Group -49.57%N/A -16.78%

In the previous week, Theracryf's average media sentiment score of 0.00 equaled Harland & Wolff Group'saverage media sentiment score.

Company Overall Sentiment
Theracryf Neutral
Harland & Wolff Group Neutral

7.8% of Theracryf shares are owned by institutional investors. Comparatively, 60.8% of Harland & Wolff Group shares are owned by institutional investors. 22.7% of Theracryf shares are owned by company insiders. Comparatively, 16.3% of Harland & Wolff Group shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Theracryf has a beta of 1.42, meaning that its share price is 42% more volatile than the S&P 500. Comparatively, Harland & Wolff Group has a beta of 3.14, meaning that its share price is 214% more volatile than the S&P 500.

Theracryf has higher earnings, but lower revenue than Harland & Wolff Group. Theracryf is trading at a lower price-to-earnings ratio than Harland & Wolff Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
TheracryfN/AN/A-£5.45M-£0.00-61.11
Harland & Wolff Group£86.91M0.00-£43.09M-£0.24N/A

Summary

Harland & Wolff Group beats Theracryf on 7 of the 10 factors compared between the two stocks.

Get Theracryf News Delivered to You Automatically

Sign up to receive the latest news and ratings for TCF and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TCF vs. The Competition

MetricTheracryfBiotechnology IndustryMedical SectorLON Exchange
Market Cap£4.73M£222.70M£6.02B£2.59B
Dividend YieldN/A3.81%5.73%5.32%
P/E Ratio-61.1198.9685.124,390.72
Price / SalesN/A5,693.57589.92101,116.96
Price / CashN/A13.1925.7727.90
Price / Book0.26106.1212.678.01
Net Income-£5.45M-£90.99M£3.32B£5.89B
7 Day Performance5.77%-0.28%0.50%0.11%
1 Month Performance-12.00%4.24%9.42%1.93%
1 Year Performance-68.79%736.29%79.11%142.77%

Theracryf Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TCF
Theracryf
N/AGBX 0.22
+4.8%
N/A-70.7%£4.73MN/A-61.1110Gap Up
High Trading Volume
HARL
Harland & Wolff Group
N/AN/AN/AN/A£14.49M£86.91M-34.9081
SOS
Sosandar
N/AGBX 5.40
-6.6%
N/A-50.0%£13.40M£37.13M-2,454.55170News Coverage
VEL
Velocity Composites
1.5256 of 5 stars
GBX 22.95
+2.9%
GBX 60
+161.4%
-23.8%£12.55M£22.70M-1,675.18102
ING
Ingenta
N/AGBX 76
flat
N/A-11.9%£11.03M£10.28M601.7465,000
NWT
Newmark Security
N/AGBX 90
-5.3%
N/AN/A£8.46M£23.04M1,353.38102Gap Down
SPO
Sportech
N/AN/AN/AN/A£8.40M£26.98M-1,680.00217,000Gap Up
High Trading Volume
IX
i(x) Net Zero
N/AN/AN/AN/A£6.99M£80.05M14.8132,200Gap Up
High Trading Volume
TREE
Cambium Global Timberland
N/AN/AN/AN/A£4.98M£4.57B11.271,250Gap Down
High Trading Volume
STL
Stilo International
N/AN/AN/AN/A£3.42M£1.42M30.001,907Gap Up
HWC
Highway Capital
N/AN/AN/AN/A£1.78MN/A0.003,630Gap Up

Related Companies and Tools


This page (LON:TCF) was last updated on 10/14/2025 by MarketBeat.com Staff
From Our Partners